A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)

S. Bellone, D. M. Roque, E. R. Siegel, N. Buza, P. Hui, E. Bonazzoli, A. Guglielmi, L. Zammataro, N. Nagarkatti, S. Zaidi, J. Lee, D. A. Silasi, G. S. Huang, V. Andikyan, S. Damast, M. Clark, M. Azodi, P. E. Schwartz, J. Tymon-Rosario, J. HaroldD. Mauricio, B. Zeybek, G. Menderes, G. Altwerger, E. Ratner, L. B. Alexandrov, A. Iwasaki, Y. Kong, E. Song, W. Dong, J. Elvin, J. Choi, A. D. Santin

Research output: Contribution to journalLetterpeer-review

13 Citations (Scopus)
Original languageEnglish
Pages (from-to)1045-1046
Number of pages2
JournalAnnals of Oncology
Issue number8
Publication statusPublished - 2021 Aug

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this